CLRB icon

Cellectar Biosciences

13 hedge funds and large institutions have $2.92M invested in Cellectar Biosciences in 2019 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 8 closing their positions.

Holders
13
Holders Change
-4
Holders Change %
-23.53%
% of All Funds
0.26%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
1
Reduced
3
Closed
8
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
BC
1
Boxer Capital
California
$2.07M 920,000
Renaissance Technologies
2
Renaissance Technologies
New York
$448K 199,002 +22,100 +12%
SFM
3
Sphera Funds Management
Israel
$197K 87,500
GPFA
4
Game Plan Financial Advisors
Ohio
$98K 43,624 +43,624 New
Vanguard Group
5
Vanguard Group
Pennsylvania
$38K 16,755
Morgan Stanley
6
Morgan Stanley
New York
$27K 12,227 -20,002 -62%
PNC Financial Services Group
7
PNC Financial Services Group
Pennsylvania
$23K 10,000 +10,000 New
LTFS
8
Ladenburg Thalmann Financial Services
Florida
$10K 4,000 -5,000 -56%
US Bancorp
9
US Bancorp
Minnesota
$6K 2,858 -1 -0%
TCM
10
Tang Capital Management
California
-235,701 Closed
PAG
11
Private Advisor Group
New Jersey
-13,400 Closed
JPMorgan Chase & Co
12
JPMorgan Chase & Co
New York
-10,505 Closed
Victory Capital Management
13
Victory Capital Management
Texas
-1,291 Closed
Bank of America
14
Bank of America
North Carolina
-31 Closed
KFS
15
Kelly Financial Services
Massachusetts
-27 Closed
AG
16
Advisor Group
Arizona
-5 Closed
IA
17
IFP Advisors
Florida
-5 Closed
CFGS
18
Concourse Financial Group Securities
Alabama
BlackRock
19
BlackRock
New York
$0 59
AWM
20
AllSquare Wealth Management
New York
$0 188
SSB
21
Sandy Spring Bank
Maryland
$0 6 +6 New
RCA
22
Ranch Capital Advisors
Florida
$0 50 +50 New